Purchase of 177Lu- Dotatate (Lutathera ®) to treat patients with neuroendocrine tumours

Official notice

Authority: The Royal Marsden NHS Foundation Trust (Central government)

GoodsAward procedure without prior publication of a call for competition

Sectors: Medical Devices & Pharma (33) Delivery: London (UKI)

Awarded value£4,500,000published contract · exc. VAT

Awarded 22 Jan 2021no call for competition

Awarded to Advanced Accelerator Application

What is being bought

Published requirement description

Purchase of 177Lu- Dotatate (Lutathera ®) to treat patients with neuroendocrine tumours

CPV: Pharmaceutical products

The lotProcurement structure

single lot · no lot value published

Lot #1The Royal Marsden Hospital NHS Foundation Trust needs to purchase 177Lu- Dotatate…

The Royal Marsden Hospital NHS Foundation Trust needs to purchase 177Lu- Dotatate (Lutathera ®) to treat patients with neuroendocrine tumours

Delivery: London

Procedure terms & legal framework

From the official record

Procedure method: Award procedure without prior publication of a call for competition
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Unspecified in notice
Recurring procurement: Unspecified in notice
First published: 22 Jan 2021, 14:31 GMT
Last source update: 22 Jan 2021, 14:31 GMT
Authority reference: DN521857
FTS notice number: 2021/S 000-001348
Classification (CPV): Pharmaceutical products
Delivery area: London (UKI)
Official registry OCID: ocds-h6vhtk-028c9a Find a Tender

Why no open competition: The procurement falls outside the scope of application of the directive
Published justification: 177Lu- Dotatate is used to treat patients with neuroendocrine tumours; currently this is the only licensed product on the market to treat this tumour and AAA is the sole distributor in the UK.

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £4,500,0001 contract exc. VAT

Contracts signed 1latest 22 Jan 2021

Awarded to	Value	Date	Status
Advanced Accelerator Application	£4,500,000 †	—	Awarded

Contracts

Contract 001348-2021-1 · Advanced Accelerator Application
Signed
22 Jan 2021
Value
£4,500,000
Status
active

Contracting authority & participating public bodies

The Royal Marsden NHS Foundation Trust

Contracting authorityCentral GovernmentBody governed by public lawHealth Unit G3, Harbour Yard, Chelsea Harbour, London, London, SW10 0XDContact name, email

Dispute resolution & review bodies

High CourtReview body London

Bidders & participating suppliers

1 commercial party on the notice

Advanced Accelerator ApplicationAwarded supplier London, London

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.